Cafestol palmitate
Cafestol palmitate is an orally active diterpene ester. Cafestol palmitate can be isolated from raw coffee beans. Cafestol palmitate enhances the activity of Glutathione S-transferase. Cafestol palmitate downregulates the expression of Akt and VEGFR2. Cafestol palmitate can be used in the research of inflammatory diseases and cardiovascular diseases.
For research use only. We do not sell to patients.
- CAS No.: 81760-46-5
- Formula: C36H58O4
- Molecular Weight:554.84
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All VEGFR Isoforms
More
Biological Activity
|
VEGFR2 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
>10 μg/mL
|
Inhibition of cyclooxygenase-2 (COX-2) activity in LPS-induced RAW 264.7 mouse macrophages assessed via measuring PGE2 levels in supernatants by enzyme immunoassay, with 2 h incubation of test samples post-COX-2 induction.
Inhibition of cyclooxygenase-2 (COX-2) activity in LPS-induced RAW 264.7 mouse macrophages assessed via measuring PGE2 levels in supernatants by enzyme immunoassay, with 2 h incubation of test samples post-COX-2 induction.
|
1934578X0800300103 |
| RAW264.7 | IC50 |
>50 μg/mL
|
Antiproliferative activity against RAW 264.7 mouse macrophages assessed as reduction in cell viability incubated for 48 hrs by XTT assay.
Antiproliferative activity against RAW 264.7 mouse macrophages assessed as reduction in cell viability incubated for 48 hrs by XTT assay.
|
1934578X0800300103 |
| HL-60 | IC50 |
>50 μg/mL
|
Antiproliferative activity against HL-60 myelomonocytic cells assessed as reduction in cell viability by MTT assay.
Antiproliferative activity against HL-60 myelomonocytic cells assessed as reduction in cell viability by MTT assay.
|
1934578X0800300103 |
| HL-60 | IC50 |
>62.5 μg/mL
|
Antiproliferative activity against HL-60 myelomonocytic cells assessed as reduction in cell viability with 10 min pre-incubation before PMA addition, 16 h total incubation with PMA, by XTT assay.
Antiproliferative activity against HL-60 myelomonocytic cells assessed as reduction in cell viability with 10 min pre-incubation before PMA addition, 16 h total incubation with PMA, by XTT assay.
|
1934578X0800300103 |
Cafestol palmitate (50 μM) inhibits the proliferation and migration of human microvascular endothelial cells by down-regulating VEGFR2 and Akt expression[2].
Cafestol palmitate (2 h) weakly inhibits COX-2 activity in LPS-induced RAW 264.7 mouse macrophages with an IC50 >10 μg/mL and shows no cytotoxicity in this cell line[3].
Cafestol palmitate (48 h) does not exhibit significant cytotoxicity in RAW 264.7 mouse macrophages, with a cell proliferation IC50 >50 μg/mL[3].
Cafestol palmitate does not exhibit significant cytotoxicity in HL-60 myelomonocytic cells, with a cell proliferation IC50 >50 μg/mL[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:RAW 264.7 mouse macrophages
-
Concentration:Unclear
-
Incubation Time:48 h
-
Result:Showed no significant cytotoxicity, with a cell proliferation IC50 value greater than 50 μg/mL.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR/Ha (female, 7 weeks of age)[1]
-
Dosage:2.5 mg/mouse (single dose, marginal activity); 2.5 mg/mouse (4 daily doses, 41% increase); 5.0 mg/mouse (4 daily doses, 3.9x control)
-
Administration:p.o.; single dose (killed 28h later); once daily for 4 days (killed 24h after last dose)
-
Result:Resulted in marginal GSH S-transferase activity in small bowel mucosa.
Increased small bowel mucosa GSH S-transferase activity by 41% relative to controls.
Increased small bowel mucosa GSH S-transferase activity to 3.9 times the control level.
Chemical Information
-
CAS No. 81760-46-5
-
Molecular Weight 554.84
-
Formula C36H58O4
-
SMILES
C[C@]12[C@@]3([H])[C@@]4(CC[C@]1([H])C5=C(OC=C5)CC2)C[C@](CC3)([H])[C@](O)(C4)COC(CCCCCCCCCCCCCCC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)